Skip to content

Press

BLV-Media Coverage
Bioluminescence Ventures to invest $477 million in biotech startups
November 2, 2023 Nov 2, 2023 BioPharma Reporter
BLV-Media Coverage
Bioluminescence Ventures debuts with $477M to speed up drug discovery
November 1, 2023 Nov 1, 2023 Biopharma Dive
BLV-Media Coverage
Life science investors close nearly $6 billion in new funds
November 1, 2023 Nov 1, 2023 STAT
BLV-Media Coverage
Bioluminescence enters biotech venture spotlight with almost $500M under management
November 1, 2023 Nov 1, 2023 Fierce Biotech
BLV-Media Coverage
Bioluminescence Ventures Emerges from Stealth with $477M AUM
November 1, 2023 Nov 1, 2023 FinSMEs
BLV-Media Coverage
Bioluminescence Ventures makes it official with $477M in assets for early-stage biotech companies
November 1, 2023 Nov 1, 2023 Endpoints
BLV-Media Coverage
VC Firm Bioluminescence Ventures Launches with $477M in Assets
November 1, 2023 Nov 1, 2023 Biospace
BLV-Press Releases
Bioluminescence Ventures Emerges from Stealth with $477M AUM
November 1, 2023 Nov 1, 2023
Portfolio-Media Coverage
ReCode raises $50 million to support developing mRNA therapies
September 22, 2023 Sep 22, 2023 Cystic Fibrosis News Today
Portfolio-Media Coverage
ReCode Raises $260M in Series B Financing to Advance Lead Programs
September 20, 2023 Sep 20, 2023 Biospace